OUTLOOK THERAPEUTICS, INC. Stock Nasdaq
Equities
US68235M1053
Biotechnology & Medical Research
Financials (USD)
Sales 2024 * | 204K | Sales 2025 * | 11.85M | Capitalization | 180M |
---|---|---|---|---|---|
Net income 2024 * | -72M | Net income 2025 * | -62M | EV / Sales 2024 * | 886 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 15.2 x |
P/E ratio 2024 * |
-2.42
x | P/E ratio 2025 * |
-3.48
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 61.15% |
Latest transcript on OUTLOOK THERAPEUTICS, INC.
Managers | Title | Age | Since |
---|---|---|---|
C. Trenary
CEO | Chief Executive Officer | 66 | 21-07-06 |
Lawrence Kenyon
DFI | Director of Finance/CFO | 58 | 15-09-14 |
Surendra Sharma
CTO | Chief Tech/Sci/R&D Officer | - | 23-01-18 |
Members of the board | Title | Age | Since |
---|---|---|---|
Randy Thurman
CHM | Chairman | 74 | 18-04-12 |
Kurt Hilzinger
BRD | Director/Board Member | 63 | 15-12-10 |
C. Trenary
CEO | Chief Executive Officer | 66 | 21-07-06 |
1st Jan change | Capi. | |
---|---|---|
+3.13% | 42.11B | |
+48.83% | 40.08B | |
+8.49% | 40B | |
-10.82% | 26.87B | |
+8.26% | 24.58B | |
-23.69% | 18.44B | |
+1.58% | 11.94B | |
+32.83% | 11.66B | |
+6.63% | 11.01B |